Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[A study on serologic markers for screening before hepatitis B vaccination]

Z Hui1, Z Zhao, L Zhang

  • 1Huhehaote Hygiene and Epidemic Prevention Station.

Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|December 1, 1994
PubMed
Summary

For hepatitis B vaccination screening, only anti-HBc testing is needed, reducing costs. Neonates and young children can be vaccinated without prior screening for hepatitis B virus infection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biological characterization of nef in long-term survivors of human immunodeficiency virus type 1 infection.

Journal of virology·1995
Same author

Virulence characteristics of Escherichia coli causing first urinary tract infection predict risk of second infection.

The Journal of infectious diseases·1995
Same author

Concordant loss of imprinting of the human insulin-like growth factor II gene promoters in cancer.

The Journal of biological chemistry·1995
Same author

Altered cAMP levels in retinas from transgenic mice expressing a rhodopsin mutant.

Biochemical and biophysical research communications·1995
Same author

Repetitive Ser-Gly sequences enhance heparan sulfate assembly in proteoglycans.

The Journal of biological chemistry·1995
Same author

The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer.

Proceedings of the National Academy of Sciences of the United States of America·1995

Area of Science:

  • Hepatology
  • Immunology
  • Public Health

Context:

  • Hepatitis B virus (HBV) infection poses a significant global health burden.
  • Screening for HBV infection before vaccination is crucial for effective public health strategies.
  • Previous screening protocols involved multiple serologic markers, increasing costs.

Purpose:

  • To evaluate the cost-effectiveness and immune efficacy of different hepatitis B screening strategies.
  • To identify the optimal serologic marker for routine screening before hepatitis B vaccination.
  • To determine if specific age groups can bypass screening.

Summary:

  • Analysis of HBV infection data from eight cities revealed that anti-HBc is the sole necessary marker for routine screening.
  • Hepatitis B surface antigen (HBsAg), anti-HBs, and anti-HBc were initially considered.

Related Experiment Videos

  • Neonates and children aged 0-3 years can receive hepatitis B vaccination without any prior screening.

    • Impact:

    • Recommends simplifying hepatitis B screening protocols, potentially lowering healthcare costs.
    • Supports direct vaccination for infants and young children, improving vaccination accessibility.
    • Aims to maintain high immune response rates while optimizing resource allocation for hepatitis B prevention.